Pegasus Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,083
Closed -$1.95M 73
2023
Q1
$1.95M Buy
28,083
+231
+0.8% +$16.3K 0.96% 38
2022
Q4
$2M Buy
27,852
+246
+0.9% +$18.5K 1.08% 35
2022
Q3
$1.96M Sell
27,606
-350
-1% -$25.4K 1.11% 37
2022
Q2
$2.15M Sell
27,956
-273
-1% -$20.8K 1.17% 36
2022
Q1
$2.06M Sell
28,229
-414
-1% -$27.8K 0.9% 39
2021
Q4
$1.79M Buy
28,643
+1,144
+4% +$67.1K 0.73% 43
2021
Q3
$1.63M Buy
27,499
+1,566
+6% +$103K 0.75% 44
2021
Q2
$1.73M Buy
25,933
+151
+0.6% +$9.85K 0.81% 42
2021
Q1
$1.63M Buy
25,782
+707
+3% +$44K 0.83% 42
2020
Q4
$1.55M Buy
25,075
+1,158
+5% +$71.2K 0.85% 41
2020
Q3
$1.44M Sell
23,917
-664
-3% -$40K 0.9% 40
2020
Q2
$1.45M Buy
24,581
+42
+0.2% +$2.51K 0.99% 38
2020
Q1
$1.37M Buy
24,539
+119
+0.5% +$7.27K 1.13% 38
2019
Q4
$1.57M Buy
24,420
+507
+2% +$29K 1.03% 40
2019
Q3
$1.21M Buy
23,913
+1,517
+7% +$71.3K 0.88% 42
2019
Q2
$1.02M Buy
22,396
+1,952
+10% +$90.9K 0.79% 43
2019
Q1
$975K Buy
20,444
+4,012
+24% +$200K 0.8% 39
2018
Q4
$854K Sell
16,432
-1,864
-10% -$100K 0.81% 43
2018
Q3
$1.14M Sell
18,296
-174
-0.9% -$10.3K 0.95% 42
2018
Q2
$1.02M Buy
18,470
+1,824
+11% +$98.5K 0.96% 40
2018
Q1
$1.05M Buy
16,646
+114
+0.7% +$7.33K 1% 42
2017
Q4
$1.01M Buy
+16,532
New +$1.03M 1.01% 41

Other funds holding BMY

Pegasus Asset Management's BMY Position: Q2 2023 in Review

Pegasus Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 28,083 shares — an estimated $1.95M sold.

Pegasus Asset Management first reported a position in BMY in Q4 2017 and held it in 22 quarters. The position peaked at $2.15M in Q2 2022. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Pegasus Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Pegasus Asset Management sold 28,083 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.95M.
  • Pegasus Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 22 quarters.
  • Pegasus Asset Management's Bristol-Myers Squibb position peaked at $2.15M in Q2 2022.
  • 2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Pegasus Asset Management's 13F filing for Q2 2023, filed 1 Aug 2023.